Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01802 |
| Species: | Homo sapiens |
| Position : | chr12:6955000-6975000 |
| Year: | 2025 |
| Title: | LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | hepatocellular carcinoma |
| PMID: | 40611281 |
| MONDO: | MONDO:0007256 |
| Tissue: | Liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | HepG2 |
| CVCL ID: | CVCL_0027 |
| Cell Type: | hepatocellular carcinoma cell |
| Cell Ontology ID: | CL:0000182 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | ChIP-RT-qPCR, qRT-PCR |
| Target gene : | PTPN6 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|